Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Lanzhou Institute Of Biological Products Co., Ltd

Clinical trials sponsored by Lanzhou Institute Of Biological Products Co., Ltd, explained in plain language.

Not yet recruiting 1 Not yet finished but already full! 1

New tetanus shot enters human safety testing

Disease control ENROLLING_BY_INVITATION

This early-stage study tests a new lab-made antibody injection against tetanus in 68 healthy adults aged 18-60. The main goal is to check safety and side effects, not to treat or prevent tetanus directly. Participants receive a single shot and are monitored for several weeks.

Phase: PHASE1 • Sponsor: Lanzhou Institute of Biological Products Co., Ltd • Aim: Disease control

Last updated Jun 27, 2026 09:00 UTC